Gwt-tud Gmbh
Clinical trials sponsored by Gwt-tud Gmbh, explained in plain language.
-
New drug may cut transfusions for rare bone marrow disorder
Disease control OngoingThis study tests a drug called luspatercept in 70 adults with a certain type of myelodysplastic syndrome (MDS) that causes severe anemia. The goal is to see if the drug can reduce or eliminate the need for regular red blood cell transfusions. Participants receive the drug by inje…
Phase: PHASE3 • Sponsor: GWT-TUD GmbH • Aim: Disease control
Last updated Apr 28, 2026 23:51 UTC
-
New hope for lymphoma patients: targeted drug combo shows promise in late-stage trial
Disease control OngoingThis study tests whether adding a targeted drug (polatuzumab vedotin) to standard chemotherapy helps people with diffuse large B-cell lymphoma that has come back or not responded to initial treatment. About 306 adults will receive either the new combo or standard therapy. The goa…
Phase: PHASE3 • Sponsor: GWT-TUD GmbH • Aim: Disease control
Last updated Apr 28, 2026 23:50 UTC